A galectina-1 (Gal-1) é uma lectina homodimérica multifuncional capaz de reconhecer e se ligar a beta-galactosídeos por meio de um domínio denominado carbohydrate recognition domain (CRD). A Gal-1 humana (Gal-1h) e a Gal-1 de camundongo (Gal-1c) mantêm 88,15% de homologia e, apesar de não existirem mutações em aminoácidos-chave do CRD, há substituições próximas a esses resíduos. Considerando as implicações dessas diferenças em estrutura e função, e que é comum a utilização de modelos murinos para estudar a função Gal-1, o presente trabalho objetiva analisar comparativamente a Gal-1c e a Gal-1h por meio de ensaios de cristalização e determinação estrutural da Gal-1c, além da avaliação comparativa da atividade lectínica da Gal-1h e da Gal-1c por glycan array e hemaglutinação. Também foi avaliada a capacidade de ambas as Gal-1 em induzir a exposição de fosfatidilserina (FS) em neutrófilos ativados provenientes de medula de camundongos normais ou deficientes de ?-2 integrina (Mac-1), de modo a investigar se a interação Gal-1/Mac-1 estaria envolvida nesse processo. Preparações homogêneas e ativas de Gal-1c e Gal-1h foram utilizadas nos ensaios. Os cristais de Gal-1c foram obtidos em 20% de polietilenoglicol 3350 e 0,2 M de fluoreto de amônio. Os dados de difração de raios X foram coletados e processados, obtendo-se uma estrutura com resolução de 2,4 Å. Observou-se que substituições de aminoácidos entre a Gal-1c e a Gal-1h estão localizadas em regiões expostas ao solvente, próximas do CRD e distantes da interface de dimerização. A análise comparativa entre Gal-1c e Gal-1h mostrou que estas substituições conferem a Gal-1c um caráter mais polar, com consequente aumento da distribuição de volume molecular. Nos ensaios de hemaglutinação, pode-se observar que é necessária uma concentração 2 vezes maior de Gal-1c para aglutinar eritrócitos humanos, de carneiro e de coelho na mesma proporção que a Gal-1h. Por meio do glycan array, pode-se determinar o perfil de ligação a glicanas de ambas as Gal-1. As duas Gal-1 apresentam afinidade por glicanas ramificadas contendo galactose terminal, e a Gal-1h apresentou maior intensidade de ligação às glicanas quando comparada à Gal-1c. Preparações de Gal-1c e Gal-1h induzem níveis semelhantes de exposição de FS na superfície de neutrófilos deficientes ou não de Mac-1, sugerindo que a interação Gal-1/Mac-1 não esteja envolvida no processo de exposição de FS na superfície de neutrófilos ativados. Assim, a diferença sequencial entre a Gal-1c e a Gal-1h é capaz de gerar diferenças estruturais consideráveis que implicam no reconhecimento diferencial de glicanas, o que, entretanto, não se reflete na capacidade de indução de FS na superfície de neutrófilos ativados. Além disso, a interação Gal-1/Mac-1 parece não participar desse processo, o que pode indicar que o papel da Gal-1 no turnover de neutrófilos, via reconhecimento fagocítico, seja um processo complexo e independente dessa interação. / Galectin-1 (Gal-1) is a homodimeric and multifunctional lectin that recognizes and binds to beta-galactoside by a carbohydrate recognition domain (CRD). Human Gal-1 (hGal-1) and mouse Gal-1 (mGal-1) are 88.15% identical, and although there are no mutations in key amino acids within the CRD, there are differences in the amino acids sequence near the CRD. Given the potential of these differences to alter overall structure and function, and the common utilization of murine models to study Gal-1 function, we sought to directly compare key biochemical features of hGal and mGal-1. Thus, we performed crystallization and structure determination assays of mGal-1, and determined the carbohydrate binding specificy of mGal-1 and hGal-1 using a glycan array and using hemagglutination assay. We also evaluated the ability of both Gal-1 to induce exposure of phosphatidylserine (PS) in activated neutrophils from the bone marrow of normal or ?-2 integrin (Mac-1) deficient mice, in order to investigate the involvement of Gal-1/Mac-1 interaction in this process. To accomplish this, homogeneous and active preparations of hGal-1 and mGal-1 were used in the study. mGal-1 crystals were obtained in 20% polyethylene glycol 3350 and 0.2 M ammonium fluoride. Data from X-ray diffraction were collected and processed, yielding a structure with a final resolution of 2.4 Å. The amino acid substitutions found between mGal-1 and hGaI-1 are detected on the solvent-exposed surfaces where the CRDs are located and not on the proteins dimerization surfaces. A comparative structural analysis between mGal-1 and hGal-1 shows that these amino acid substitutions confer to mGal-1 a greater number of ionizable residues, polar character, appearance of the acid regions clustered, and a slight increase of volume distribution. In hemagglutination assays, twice the concentration of mGal-1 was required to cause equivalent agglutination of human, sheep or rabbit erythrocytes as hGal-1. Glycan array analysis demonstrated that both galectins have affinity for branched glycans containing terminal galactose residues. However, hGal-1 appeared to display higher levels of binding that mGal-1. Preparations of mGal-1 and hGal-1 induced similar levels of PS exposure on normal or Mac-1 deficient neutrophils, suggesting that the interaction Gal-1/Mac-1 is not involved in this process. Thus, hGal-1 and mGal-1 appear to possess considerable differences in glycan recognition that likely reflects subtle difference in amino acid sequence. Furthermore, the interaction Gal-1/Mac-1 do not appear to participate in this PS exposure process, which suggest that other Gal-1 receptors are likely important in this process.

O mecanismo responsável pela exposição da fosfatidilserina (PS) nas membranas celulares não está bem definido. Uma atividade dependente de ATP está envolvida, provavelmente uma ATPase tipo-P. ATPases tipo P são uma família de proteínas transmembranares envolvidas no transporte de metais, íons e fosfolipídios através da membrana plasmática. As P4 ATPases translocam aminofosfolipidios (APTLs) como a PS durante a apoptose. No entanto, o sentido do transporte de PS pela APLT não está claramente definido. Os macrófagos reconhecem a PS exposta na superfície das células apoptóticas, o que inibe sua capacidade microbicida. Formas promastigotas e amastigotas de Leishmania ssp. sofrem apoptose, porém a exposição de PS na superfície dos promastigotas sempre leva à morte, enquanto que nos amastigotas não está necessariamente associada à morte e permite a internalização desses protozoários e sua sobrevivência no macrófago. Esse trabalho teve como objetivo a caracterização molecular da APLT de L. (L.) amazonensis e a avaliação de seu papel na exposição de PS nesse parasita. / The mechanism responsible for phosphatidylserine (PS) exposure in biological membranes is still an open subject. An ATP-dependent activity is involved, probably a Type P- ATPase. Type P ATPases are a family of transmembrane proteins involved in the transport of metals, ions and phospholipids across plasma membrane. P4 ATPases mediate phospholipid transport (APLT) as PS during the process of cell death by apoptosis. However, the direction (inwards or outwards) of this translocation has not been defined. Macrophages recognize exposed PS on the surface of apoptotic cells, what inhibits their microbicidal capacity. Promastigotes and amastigotes of Leishmania ssp. die by apoptosis, but PS exposure on promastigotes always leads to apoptosis, whereas PS exposure by amastigotes is not necessarily associated to death and allows their internalization and survival in the macrophage. This work aimed to characterize APLT from L. (L.) amazonensis and to evaluate its role in PS exposure in this parasite.

Promastigotas de Leishmania são encontradas no trato digestivo do inseto vetor e podem ser cultivados em alguns meios de cultura, onde ocorre a diferenciação regulada geneticamente entre procíclicos e metacíclicos infectivos. Amastigotas são intracelulares e irão se estabelecer e se multiplicar dentro dos vacúolos parasitóforos dos macrófagos. Os metacíclicos e os amastigotas possuem capacidade de evasão do sistema de defesa do hospedeiro vertebrado e conseguem estabelecer uma relação parasita/hospedeiro bem-sucedida. A apoptose, em organismos multicelulares, é uma forma controlada geneticamente de suicídio celular. A eliminação das células apoptóticas é feita pelos fagócitos sem que seja induzida uma resposta inflamatória. Em Leishmania, os eventos da apoptose parecem seguir os mesmos dos encontrados em metazoários, tais como: queda do potencial da mitocôndria, ativação de caspases, clivagem de substratos naturais de caspases, além da externalização de fosfatidilserina (PS) e seu papel na modulação da fagocitose. Nossos dados demonstraram que Leishmania é capaz de mimetizar e utilizar um dos fenômenos observados na apoptose em metazoários, a exposição de PS, como um mecanismo adaptativo para se estabelecer como um parasita de mamíferos. / Promastigotes of Leishmania are found in the midgut environment of the vector insect and can be grown in some culture medium. In culture the genetically regulated differentiation from procyclic to infective metacyclic can be observed. Amastigotes are intracellular parasites and which multiply inside phagolysosomes of macrophages. Metacyclics and amastigotes are endowed with the capacity to evade from the innate and adaptive immune system of the vertebrate host and to establish successful infections. Apoptosis, in multicellular organisms, is a form genetically controlled cellular suicide. The elimination of apoptotic cells is made by phagocytes without initiating an inflammatory event. In Leishmania, the events of apoptosis are similar to those observed in multicellular organisms such as: decrease in mitochondrial transmembrane potential, caspase activation, cleavage of caspase substrates besides exposure of phosphatidylserine (PS) and its role in the modulation of phagocytosis. Our data showed that Leishmania is capable of mimicking one of the features of apoptosis, mainly PS exposure, and to use as an adaptive mechanism for survival in mammalian hosts.

No description available.

<p>  </p> <p>Ebola virus (EBOV) infection remains to be a challenge to human health by its high mortality rate. Though it has been discovered for almost 50 years, there are only two antibody-based therapies approved today, and the mortality rate is still greater than 30% with the treatment. Authentic EBOV studies are strictly limited to biosafety level-4 (BSL-4) labs, which slows the development of treatment. While more simple and safer systems have been developed to understand different stages of EBOV infection, such as the matrix protein (VP40) virus-like particle (VLP) and minigenome systems, we still lack a systematical view of EBOV infection. On the other hand, mathematical modeling has been used to assist biological and medical studies for many years, as it has the advantage of integrating data and providing quantitative insight to a biosystem. In our study, we took advantage of mathematical modeling and build the primary ordinary differential equation-based (ODE-based) model of EBOV at subcellular level step by step. We built the budding pathway of EBOV VP40 first, calibrated and validated our model with experimental data. We proposed that phosphatidylserine (PS) can directly influence the stability of VP40 filaments and the budding process of VLPs. Also, the oligomerization of VP40 filaments may follow the nucleation-elongation process. Next, we conducted in-silico simulation to evaluate the treatment efficiency of fendiline, a drug lowering cell membrane PS level, in treating EBOV. We found that while in general, fendiline can decrease VLP production, there can be fendiline-induced VLP production increases at certain time points due to slow filament growth or fast VLP budding rates. Also, we concluded that fendiline is relatively more effective when applied in the budding stage of EBOV life cycle. Moreover, fendiline efficacy may increase when applied with a VLP budding step targeted treatment. Finally, we integrated nucleoprotein (NP) into our model. We reproduced the two-stage interaction between NP and VP40 and predict that NP increases VLP production through influencing filament oligomerization and VLP budding steps. Also, the dual-effect of NP on VLP production may exist, as a too high NP/VP40 production ratio can decrease VLP production. From the aspect of protein expression time, we found that a bit earlier NP production than VP40 production is beneficial for both inclusion body-containing (IB-containing) VLP production and prevention in energy waste on production of VLPs without IBs. Overall, we have built a solid foundation towards a mathematical EBOV model and demonstrated the value of models in assisting experimental EBOV studies.</p>

No description available.

No description available.

Toxoplasma gondii ist ein weit verbreiteter, obligat-intrazellulärer, einzelliger Parasit, der die lebensbedrohliche Krankheit Toxoplasmose in Menschen und Tieren hervorrufen kann. Der schnell replizierende Parasit benötigt erhebliche Mengen an Phospholipiden zur Biogenese intra- und extrazellulärer Membranen. Phosphatidylethanolamin (PtdEtn) ist ein wichtiges und ubiquitäres Phospholipid in Pro- und Eukaryoten und das zweithäufigste Lipid in T. gondii. Dieses kann de novo über den CDP-Ethanolamin Stoffwechselweg oder durch Decarboxylierung von Phosphatidylserin synthetisiert werden. Im Rahmen dieser Arbeit konnte die Expression von zwei distinkten Phosphatidylserin Decarboxylasen (PSDs) in T. gondii nachgewiesen werden: TgPSD1pv ist partiell löslich und wird über Dichte Granula in die Parasitophore Vakuole sekretiert, während sich TgPSD1mt im Mitochondrium von Tachyzoiten befindet. TgPSD1mt ist in der Lage einen Ethanolamin-auxotrophen S. cerevisiae Stamm zu komplementieren. Ein Knock-down von TgPSD1mt in T. gondii verursacht eine verlangsamte Parasitenreplikation, welche zu einem verminderten in vitro Wachstum führt. Der PtdEtn-Gehalt in der Mutante bleibt unverändert, was auf eine stringente Homöostase des zellulären PtdEtn Reservoirs durch alternative Lipidbiogenesewege hindeutet. Tatsächlich verfügt T. gondii zusätzlich über einen aktiven CDP-Ethanolamin Stoffwechselweg im Endoplasmatischen Retikulum, welcher den Verlust von TgPSD1mt partiell kompensieren kann. Das zweite, sekretierte TgPSD1pv-Enzym hingegen scheint für das Parasitenwachstum in vitro entbehrlich zu sein. Infektionsversuche mit radioaktiv markierten Wirtszellen zeigten zudem eine Aufnahme von PtdEtn oder PtdEtn-Derivaten in intrazellulär replizierenden Tachyzoiten. Diese Ergebnisse demonstrieren eine außergewöhnliche Kompartmentalisierung und Plastizität der PtdEtn-Synthese in T. gondii. / Toxoplasma gondii is a remarkably successful and widespread obligate intracellular protozoan parasite, which can cause the potentially life threatening disease Toxoplasmosis in humans and animals. The fast proliferating parasite requires a significant amount of phospholipids for biogenesis of organelles and enclosing vacuolar membranes. Phosphatidylethanolamine (PtdEtn) is one of the most ubiquitous phospholipids and the second most abundant lipid in T. gondii. It can be produced de novo by the CDP-ethanolamine pathway or by decarboxylation of phosphatidylserine. This work revealed the expression of two distinct PtdSer decarboxylase (PSD) enzymes in T. gondii: One of which is Coccidia-specific and partially soluble and secreted into the parasitophorous vacuole via dense granules (TgPSD1pv), and a second enzyme that localizes in the mitochondrion (TgPSD1mt) of tachyzoites. The mitochondrial PSD can complement a S. cerevisiae mutant auxotrophic for ethanolamine. A conditional knockdown of the TgPSD1mt gene impairs the parasite growth in vitro. Surprisingly, the mutant displayed an unaltered total PtdEtn content, which suggests a stringent homeostasis of the cellular PtdEtn pool by alternative routes of lipid biogenesis. Consistently, the parasite encodes an active CDP-ethanolamine pathway in the endoplasmic reticulum. Metabolic labeling of the TgPSD1mt mutant displayed an increased utilization of ethanolamine into PtdEtn, indicating an upregulation of the de novo CDP-ethanolamine pathway. Likewise, exogenous ethanolamine partially restored the growth phenotype of the mutant. In contrast, the TgPSD1pv enzyme is dispensable for the parasite growth. Host cell pre-labeling with radioactive ethanolamine indicated a potential uptake of host-derived PtdEtn or PtdEtn-derivates by intracellular parasites. Taken together, these results demonstrate an exceptional compartmentalization and plasticity of the PtdEtn synthesis in T. gondii.

Toxoplasma gondii ist wohl der am besten an den Menschen und Tieren angepasste Parasit der Welt und eine der Hauptursachen für Abtreibungen und opportunistsiche Infektionen. Das Verständnis der Stoffwechselflexibilität dieses Parasiten ist essentiel um seine Anpassungsfähigkeit nachzuvollziehen. Lipide sind Grundbestandteile der biologischen Membranen. Doch in den letzten Jahrzehnten sind neben der Biogenese der Membranen noch weitere Funktionen entdeckt worden. Hier berichten wir zum ersten Mal über Phosphatidylthreonin (PtdThr) als Hauptphospholipid von T. gondii und zeigen seine Beziehung mit seinem archetypischen Analogon, Phosphatidylserin (PtdSer). Wir identifizieren auch ein neues Parasitenenzym (TgPTS), welches von der regulären PtdSer-Synthase-Familie abgewichen ist und dieses sonst selten vorkommende Lipid synthetisiert. Die Gendeletion von TgPTS stoppte nicht nur die Synthese von PtdThr, sondern auch stark beeinträchtigt den lytischen Zyklus von T. gondii, insbesondere beim Aus- und Eintritt in die Wirtszellen, ohne dabei die Replikation des Parasiten zu verhindern. Unsere Arbeit zeigt, dass entweder ein niedriger Ca2+-Pool oder eine verminderte Ca2+-Mobilisierung aus dem endoplasmatischen Retikulum des Parasiten eine reduzierte Motilität verursachen, welche den beobachteten Phänotypen zugrunde liegt. Darüber hinaus fehlt es den mutierten Parasiten an PtdThr (Δtgpts), sie sind avirulent und üben vollständigen Schutz gegen akute und chronische Toxoplasmose in einem Mausmodell aus. Diese Ergebnisse verdeutlichen die Bedeutung der Parasitenlipide als therapeutisches Ziel und von genetisch abgeschwächten Stämmen für die Entwicklung von wirksamen Impfstoffen gegen Kokzidien. / Toxoplasma gondii is arguably the most succesful parasite in Earth and a major cause of abortion and opportunistic infections in humans and livestock. Understanding the metabolic flexibility of this parasite is essential to comprehend its adaptability. Lipids are basic components of biological membranes. However, in the last decades non-customary roles for lipids beyond membrane biogenesis have been recognized. Here we report for the first time phosphatidylthreonine (PtdThr) as a major phospholipid in T. gondii and show its relationship with its archetypical analog, phosphatidylserine (PtdSer). We also identify a novel parasite enzyme (TgPTS), which diverged from the mainstream PtdSer-synthase family to produce this otherwise rare lipid. Genetic ablation of TgPTS not only abolished PtdThr synthesis, but also impaired severely the lytic cycle of T. gondii, particularly the egress but also the invasion into host cells without affecting the parasite replication. Our work indicates that, either a lower Ca2+ pool and/or a diminished Ca2+ mobilization from the parasite endoplasmic reticulum cause a reduced gliding motility, which underlies the observed phenotypes. Moreover, the mutant parasites lacking PtdThr (Δtgpts) are avirulent and exert full protection against both, acute and chronic toxoplasmosis in a murine model. These results highlight the importance of parasite lipids as therapeutic targets and of genetically-attenuated strains in the development of effective vaccines against coccidian parasites.

Made available in DSpace on 2017-07-24T19:22:04Z (GMT). No. of bitstreams: 1 Leticia Antonelo Campos.pdf: 2246502 bytes, checksum: 0d9288acf39d871d8aedcd4d1fc4e5ca (MD5) Previous issue date: 2014-02-27 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / The biofilm accumulation in the subgingival region produces an inflammatory process that can lead to alveolar bone resorption and periodontal attached loss through due inflammatory mediators that induce the production and activation of enzymes and periodontal degradation tissues. Phosphatidylserine liposomes can mimic apoptotic cells effects and may modulate the host inflammatory response. This present study evaluated the effect of phosphatidylserine liposomes on the inflammatory response and alveolar bone loss ligatureinduced in rats. We used a phosphatidylserine liposome solution preparation in order to evaluate the cytotoxicity in lineage osteoblastic cells. The antiinflammatory effect was evaluated by mouse ear edema (topical application) and rat paw edema (systemic application) methods. Then, we evaluated the phosphatidylserine liposome action on gingival inflammatory response and alveolar bone loss ligature-induced in rats. The results showed phosphatidylserine liposome 50 and 250 μM concentrations were safer considering cell viability and proliferation. The phosphatidylserine liposome gel (topical application) had no anti-inflammatory action on mouse ear edema model and alveolar bone loss ligature-induced in rats. The phosphatidylserine liposome solution (systemic application) has anti-inflammatory action on rat paw edema. Although, we did not observe an effect on alveolar bone loss ligatureinduced. We conclude phosphatidylserine liposome gel and solution are easy to prepare and they have low cost. Phosphatidylserine liposoma solution (systemic application) have antiinflammatory effect on rat paw edema model. On the other hand, it have no effect on alveolar bone loss ligature-induced in rat. / O acúmulo de biofilme na região subgengival produz um processo inflamatório que pode conduzir à reabsorção óssea e perda de inserção, devido mediadores inflamatórios que induzem a produção e ativação de enzimas e degradação dos tecidos periodontais. Lipossomas de fosfatidilserina mimetizam o efeito de células apoptóticas podendo modular a resposta inflamatória do hospedeiro. Este estudo avaliou o efeito do tratamento com lipossomas de fosfatidilserina sobre a reposta inflamatória e perda óssea alveolar induzida por ligadura em ratos. Utilizamos uma preparação de solução de lipossomas de fosfatidilserina avaliando a citotoxicidade em uma linhagem de células osteoblásticas. Avaliamos a ação anti-inflamatória por meio dos métodos de edema de orelha em camundongos (aplicação tópica) e edema de pata em ratos (aplicação sistêmica). Em seguida, avaliamos a ação de lipossomas de fosfatidilserinana na resposta inflamatória gengival e perda óssea alveolar induzida por ligadura em ratos. Os resultados mostraram que as concentrações de 50 e 250 μM dos lipossomas de fosfatidilserina foram seguras, considerando a viabilidade e proliferação celular. O gel lipossomal de fosfatidilserina (aplicação tópica) não teve ação anti-inflamatória no modelo de edema de orelha em camundongo nem na perda óssea induzida por ligadura em ratos. A solução de lipossomas de fosfatidilserina (aplicação sistêmica) teve ação anti-inflamatória no modelo de edema de pata em ratos. Porém, não observamos efeito na perda óssea induzida por ligadura. Pode-se concluir que o gel e a solução de lipossomas de fosfatidilserina são de fácil preparo e de baixo custo. Lipossomas de fosfatidilserina em solução (aplicação sistêmica) possui efeito anti-inflamatório no modelo edema de pata em ratos. Por outro lado, não interferiu na perda óssea alveolar induzida por ligadura em ratos.